50 Shades Lighter (than Air): an introduction to hydrogen
4 mins. to read
Hybridan’s Derren Nathan introduces the hydrogen sector and some of the key players in this expanding sector.
Derren Nathan
Stocks in Focus: Sareum Holdings
7 mins. to read
A developer of best-in-class targeted therapeutics has had its near- clinic ready TYK2/JAK 1 inhibitor programme earmarked as a potential therapy for severe Covid-19.
Stocks in Focus: Rural Broadband Solutions
10 mins. to read
Derren Nathan of Hybridan stockbrokers takes a detailed look at Rural Broadband Solutions, which specialises in providing fibre quality broadband to rural communities.
Stocks in Focus: Symphony Environmental Technologies
10 mins. to read
The tide is beginning to turn for plastic technologies firm Symphony Environmental, writes Derren Nathan of Hybridan.
Stocks in Focus: Physiomics
6 mins. to read
Derren Nathan of Hybridan explains why Physiomics continues to attract funding to progress its evolving personalised medicine tools.
Stocks in Focus: DXS International
6 mins. to read
An accredited NHS software creator is poised to enter a new growth phase with next-generation, digital, clinical-support engines, as healthcare systems worldwide feel the strain.